T TITAN PHARMACEUTICALS
Dead / Cancelled — Cancelled — Section 8 (as of 02 Jan 2026)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87278812
- Registration number
- 5782129
- Mark type
- Design + words
- Filed
- 22 Dec 2016
- Published for opposition
- 28 Aug 2018
- Registered
- 18 Jun 2019
- Attorney of record
- Jennifer Lee Taylor
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, treatment for central nervous disorders, cancer, hematological disorders, endocrine disorders, metabolic disorders, inflammatory disorders, gastrointestinal disorders, liver disease, heart disorders, lung and bronchial disease, blood cardiovascular disease, circulatory system disease, intestinal disorders, bone disease, autoimmune disorders and disorders of the immune systems, infectious disease and enzyme deficiency disease; implantable delivery systems comprised of sustainable release drugs for treatment for central nervous disorders and other serious and life-threatening diseases, cancer, hematological disorders, endocrine disorders, metabolic disorders, inflammatory disorders, gastrointestinal disorders, liver disease, heart disorders, lung and bronchial disease, blood cardiovascular disease, circulatory system disease, intestinal disorders, bone disease, autoimmune disorders and disorders of the immune systems, infectious disease and enzyme deficiency disease; pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based subdermal matrix formulation for the sustained release of drugs in the treatment of opiate addiction; pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based matrix formulation for the sustained release of drugs in the treatment of central nervous system disorders and other serious and life-threatening diseases
Owner
- Titan Pharmaceuticals, Inc., South San Francisco, CA, US
- Titan Pharmaceuticals, Inc., South San Francisco, CA, US
- Titan Pharmaceuticals, Inc., South San Francisco, CA, US
Prosecution history
- 02 Jan 2026 — CANCELLED SEC. 8 (6-YR)
- 18 Jun 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 18 Jun 2019 — REGISTERED-PRINCIPAL REGISTER
- 17 May 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 16 May 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 05 May 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 23 Apr 2019 — USE AMENDMENT FILED
- 05 May 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 23 Apr 2019 — TEAS STATEMENT OF USE RECEIVED
- 19 Apr 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Apr 2019 — SOU EXTENSION 1 GRANTED
- 17 Apr 2019 — SOU EXTENSION 1 FILED
- 17 Apr 2019 — SOU TEAS EXTENSION RECEIVED
- 23 Oct 2018 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 28 Aug 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED